scholarly journals Microarray and RNA in situ hybridization assay for recurrence risk markers of breast carcinoma and ductal carcinoma in situ: Evidence supporting the use of diverse pathways panels

2019 ◽  
Vol 121 (2) ◽  
pp. 1736-1746 ◽  
Author(s):  
Mark Francis Evans ◽  
Pamela Mary Vacek ◽  
Brian Lee Sprague ◽  
Gary Stephen Stein ◽  
Janet Lee Stein ◽  
...  
Keyword(s):  
In Situ Hybridization ◽  
Breast Carcinoma ◽  
Ductal Carcinoma In Situ ◽  
Carcinoma In Situ ◽  
Ductal Carcinoma ◽  
Recurrence Risk ◽  
Hybridization Assay ◽  
Risk Markers ◽  
Rna In Situ Hybridization

scholarly journals Stromal characteristics are adequate prognosticators for recurrence risk in ductal carcinoma in situ of the breast

2019 ◽  
Vol 45 (4) ◽  
pp. 550-559 ◽  
Author(s):  
Mieke Van Bockstal ◽  
Kathleen Lambein ◽  
Ann Smeets ◽  
Laurence Slembrouck ◽  
Patrick Neven ◽  
...  
Keyword(s):  
Ductal Carcinoma In Situ ◽  
Carcinoma In Situ ◽  
Ductal Carcinoma ◽  
Recurrence Risk

Relationship of Breast Magnetic Resonance Imaging to Outcome After Breast-Conservation Treatment With Radiation for Women With Early-Stage Invasive Breast Carcinoma or Ductal Carcinoma in Situ

2008 ◽  
Vol 26 (3) ◽  
pp. 386-391 ◽  
Author(s):  
Lawrence J. Solin ◽  
Susan G. Orel ◽  
Wei-Ting Hwang ◽  
Eleanor E. Harris ◽  
Mitchell D. Schnall
Keyword(s):  
Breast Carcinoma ◽  
Ductal Carcinoma In Situ ◽  
Carcinoma In Situ ◽  
Ductal Carcinoma ◽  
Early Stage ◽  
Breast Mri ◽  
Invasive Breast Carcinoma ◽  
Breast Conservation Treatment ◽  
Mri Study

Purpose To determine the relationship of breast magnetic resonance imaging (MRI) to outcome after breast-conservation treatment (BCT) with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. Patients and Methods A total of 756 women with early stage invasive breast carcinoma or ductal carcinoma in situ underwent BCT including definitive breast irradiation during 1992 to 2001. At the time of initial diagnosis and evaluation, routine breast imaging included conventional mammography. Of the 756 women, 215 women (28%) had also undergone a breast MRI study, and 541 women (72%) had not undergone a breast MRI study. The median follow-up after treatment was 4.6 years (range, 0.1 to 13.5 years). Results For the women with a breast MRI study compared with the women without a breast MRI study, there were no differences in the 8-year rates of any local failure (3% v 4%, respectively; P = .51) or local-only first failure (3% v 4%, respectively; P = .32). There were also no differences between the two groups for the 8-year rates of overall survival (86% v 87%, respectively; P = .51), cause-specific survival (94% v 95%, respectively; P = .63), freedom from distant metastases (89% v 92%, respectively; P = .16), or contralateral breast cancer (6% v 6%, respectively; P = .39). Conclusion The use of a breast MRI study at the time of initial diagnosis and evaluation was not associated with an improvement in outcome after BCT with radiation.

Sign in / Sign up

Export Citation Format

Share Document